Cargando…
Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261890/ https://www.ncbi.nlm.nih.gov/pubmed/35798694 http://dx.doi.org/10.1038/s41392-022-01095-8 |
_version_ | 1784742379915313152 |
---|---|
author | Liu, Xiaolei Liu, Yi Jin, Xuemin He, Zhanlong Huang, Zhen Sun, Shumin Gao, Yuwei Li, Jingyu Ning, Qin Xie, Zhongping Jin, Ningyi Liu, Mingyuan |
author_facet | Liu, Xiaolei Liu, Yi Jin, Xuemin He, Zhanlong Huang, Zhen Sun, Shumin Gao, Yuwei Li, Jingyu Ning, Qin Xie, Zhongping Jin, Ningyi Liu, Mingyuan |
author_sort | Liu, Xiaolei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9261890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-92618902022-07-08 Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques Liu, Xiaolei Liu, Yi Jin, Xuemin He, Zhanlong Huang, Zhen Sun, Shumin Gao, Yuwei Li, Jingyu Ning, Qin Xie, Zhongping Jin, Ningyi Liu, Mingyuan Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-07-07 /pmc/articles/PMC9261890/ /pubmed/35798694 http://dx.doi.org/10.1038/s41392-022-01095-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter Liu, Xiaolei Liu, Yi Jin, Xuemin He, Zhanlong Huang, Zhen Sun, Shumin Gao, Yuwei Li, Jingyu Ning, Qin Xie, Zhongping Jin, Ningyi Liu, Mingyuan Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques |
title | Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques |
title_full | Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques |
title_fullStr | Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques |
title_full_unstemmed | Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques |
title_short | Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques |
title_sort | rapidly developable therapeutic-grade equine immunoglobulin against the sars-cov-2 infection in rhesus macaques |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261890/ https://www.ncbi.nlm.nih.gov/pubmed/35798694 http://dx.doi.org/10.1038/s41392-022-01095-8 |
work_keys_str_mv | AT liuxiaolei rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT liuyi rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT jinxuemin rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT hezhanlong rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT huangzhen rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT sunshumin rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT gaoyuwei rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT lijingyu rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT ningqin rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT xiezhongping rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT jinningyi rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques AT liumingyuan rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques |